PT97375A - Processo de preparacao de derivados substituidos da indolona e dos seus intermediarios - Google Patents

Processo de preparacao de derivados substituidos da indolona e dos seus intermediarios

Info

Publication number
PT97375A
PT97375A PT97375A PT9737591A PT97375A PT 97375 A PT97375 A PT 97375A PT 97375 A PT97375 A PT 97375A PT 9737591 A PT9737591 A PT 9737591A PT 97375 A PT97375 A PT 97375A
Authority
PT
Portugal
Prior art keywords
pct
preparation
indolone
intermediaries
compound
Prior art date
Application number
PT97375A
Other languages
English (en)
Other versions
PT97375B (pt
Inventor
Robert Giles
Timothy Charles Walsgrove
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PT97375A publication Critical patent/PT97375A/pt
Publication of PT97375B publication Critical patent/PT97375B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/40—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups and esterified hydroxy groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/78—Benzoic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT97375A 1990-04-17 1991-04-16 Processo de preparacao de derivados substituidos da indolona e dos seus intermediarios PT97375B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909008605A GB9008605D0 (en) 1990-04-17 1990-04-17 Process

Publications (2)

Publication Number Publication Date
PT97375A true PT97375A (pt) 1992-01-31
PT97375B PT97375B (pt) 1998-08-31

Family

ID=10674534

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97375A PT97375B (pt) 1990-04-17 1991-04-16 Processo de preparacao de derivados substituidos da indolona e dos seus intermediarios

Country Status (29)

Country Link
US (1) US5336781A (pt)
EP (1) EP0526529B1 (pt)
JP (2) JP2788548B2 (pt)
KR (1) KR0180215B1 (pt)
CN (1) CN1027892C (pt)
AP (1) AP184A (pt)
AT (1) ATE144251T1 (pt)
AU (2) AU640006B2 (pt)
CA (1) CA2080221C (pt)
CY (1) CY1981A (pt)
DE (1) DE69122753T2 (pt)
DK (1) DK0526529T3 (pt)
ES (1) ES2094812T3 (pt)
FI (1) FI101148B (pt)
GB (1) GB9008605D0 (pt)
GR (1) GR3022261T3 (pt)
HK (1) HK3097A (pt)
HU (1) HU214822B (pt)
IE (1) IE911262A1 (pt)
IL (7) IL111030A (pt)
MA (1) MA22133A1 (pt)
MY (1) MY109628A (pt)
NO (2) NO178396C (pt)
NZ (1) NZ237819A (pt)
PL (1) PL166736B1 (pt)
PT (1) PT97375B (pt)
SA (1) SA91110352B1 (pt)
WO (1) WO1991016306A1 (pt)
ZA (1) ZA912782B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
DE69131775T2 (de) * 1990-09-28 2000-04-20 Smithkline Beecham Corp. Verfahren zur Herstellung wasserlöslicher Camptothecinanaloge, sowie die Verbindungen 10-Hydroxy-11-C(1-6)-alkoxycamptothecin
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
WO2005074387A2 (en) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
WO2005105741A1 (en) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
WO2005080333A1 (en) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Process for purification of ropinirole
US20070254941A1 (en) * 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
CN103130704B (zh) * 2013-03-11 2019-03-22 上海奥博生物医药技术有限公司 一种制备4-(2-羟乙基)-1，3-二氢-2h-吲哚-2-酮的新方法
CN103145604A (zh) * 2013-03-19 2013-06-12 上海奥博生物医药技术有限公司 一种制备罗匹尼罗关键中间体的方法
CN105418482A (zh) * 2015-11-23 2016-03-23 东南大学 一种改进的盐酸罗匹尼罗的制备方法
CN108440376B (zh) * 2018-05-08 2020-06-05 中国科学院成都生物研究所 一种盐酸罗匹尼罗的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1154976A (en) * 1967-02-21 1969-06-11 Pfizer Ltd N-Phenyl Indoline Derivatives
JPS53101333A (en) * 1977-02-14 1978-09-04 Sagami Chem Res Center 3-acyloxymethyl-3,4:5,6-diepoxycyclohexane-1,2-diol and
IT1171624B (it) * 1980-11-12 1987-06-10 Thomae Gmbh Dr K Indolinoni dotati di proprieta' farmaceutiche e procedimento per la loro produzione
US4588790A (en) * 1982-03-24 1986-05-13 Union Carbide Corporation Method for fluidized bed polymerization
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US4593033A (en) * 1985-04-24 1986-06-03 Merck & Co., Inc. Substituted indeno[2,1-c] pyridines useful as calcium channel blockers
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process

Also Published As

Publication number Publication date
KR0180215B1 (ko) 1999-03-20
NO178396C (no) 1996-03-20
WO1991016306A1 (en) 1991-10-31
IL111030A (en) 1995-11-27
AU640006B2 (en) 1993-08-12
IL111029A (en) 1995-11-27
US5336781A (en) 1994-08-09
GR3022261T3 (en) 1997-04-30
FI924674A0 (fi) 1992-10-15
HUT64742A (en) 1994-02-28
PL166736B1 (pl) 1995-06-30
DK0526529T3 (da) 1996-11-18
NO1999012I1 (no) 1999-06-18
EP0526529A1 (en) 1993-02-10
CY1981A (en) 1997-09-05
HK3097A (en) 1997-01-10
IL111029A0 (en) 1994-11-28
EP0526529B1 (en) 1996-10-16
ZA912782B (en) 1992-11-25
SA91110352B1 (ar) 2001-11-12
NO924028L (no) 1992-10-16
AU3566993A (en) 1993-06-03
ATE144251T1 (de) 1996-11-15
CA2080221A1 (en) 1991-10-18
CN1056686A (zh) 1991-12-04
AP184A (en) 1992-06-30
CA2080221C (en) 2000-11-14
AU646771B2 (en) 1994-03-03
JPH05506029A (ja) 1993-09-02
DE69122753T2 (de) 1997-05-07
PT97375B (pt) 1998-08-31
FI924674A (fi) 1992-10-15
HU9203261D0 (en) 1992-12-28
NO178396B (no) 1995-12-11
DE69122753D1 (de) 1996-11-21
HU214822B (hu) 1998-06-29
IL111028A (en) 1995-11-27
JP3044013B2 (ja) 2000-05-22
AU7656291A (en) 1991-11-11
AP9100251A0 (en) 1991-04-30
IL97867A (en) 1995-11-27
IL111028A0 (en) 1994-11-28
IL97867A0 (en) 1992-06-21
ES2094812T3 (es) 1997-02-01
JP2788548B2 (ja) 1998-08-20
IE911262A1 (en) 1991-10-23
MY109628A (en) 1997-03-31
FI101148B (fi) 1998-04-30
NZ237819A (en) 1993-05-26
JPH10251205A (ja) 1998-09-22
GB9008605D0 (en) 1990-06-13
IL111030A0 (en) 1994-11-28
MA22133A1 (fr) 1991-12-31
CN1027892C (zh) 1995-03-15
NO924028D0 (no) 1992-10-16

Similar Documents

Publication Publication Date Title
PT97375A (pt) Processo de preparacao de derivados substituidos da indolona e dos seus intermediarios
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
PT96857A (pt) Processo para a preparacao de oxetanonas
PT98545A (pt) Processo para a preparacao de novos conjugados de antraciclinas utilizados como ligantes de agentes bioactivos
PT96890A (pt) Processo para a preparacao de novos derivados com estrutura naftalenica e de composicoes farmaceuticas que os contem
PT97745A (pt) Processo de preparacao estero-selectiva de derivados da fenil-iso-serina
AU548974B2 (en) Oligoglucoside derivatives
ES2005746A6 (es) Un procedimiento para la preparacion de un haluro de piridinio.
BR9408223A (pt) Composto derivado de 4-benzoilisoxazol processo de preparação composição herbicida método de controle herbicida e compostos intermediarios
PT644188E (pt) Novo processo de preparacao de derivados sulfurados do imidazole e novos intermediarios obtidos
FI963168A (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia indaani-2-merkaptoasetyyliamiddisulfidijohdannaisia
DE3750267D1 (de) Herstellung von Piperidinylcyclopentylheptensäure-Derivaten.
PT89029A (pt) Processo para a preparacao de novos derivados substituidos de 20,21-dinoreburnamenina
ES2139670T3 (es) Derivados de 1-fenilpirrolidona con actividad optica y preparacion de los mismos.
KR950702249A (ko) 3-히드록시페닐아세트산의 제조방법(Method of preparing 3-Hydroxyphenylacetic Acid)
PT99378A (pt) Processo para a preparacao de intermediarios uteis para a preparacao de acido 4,5-difluoroantranilico
ES2115950T3 (es) Preparacion de n-cianoditioiminocarbonatos disustituidos, simetricos o asimetricos.
FR2446818A1 (fr) Tetrahydro-2h-benzo(c)pyrroles utiles comme intermediaires
AR248017A1 (es) Procedimiento para preparar 1 1 1 1 1
BR8804664A (pt) Processo para a preparacao de um composto e compostos
AR241406A1 (es) Metodo para la preparacion de derivados amino alcanolicos aromaticos policiclicos.
BG49444A1 (en) Acylureidoamynotiasolylni derivatives and method for their preparation

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910912

FG3A Patent granted, date of granting

Effective date: 19980506

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130506